These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia. Barber KE; Rybak MJ; Sakoulas G J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677 [No Abstract] [Full Text] [Related]
7. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches. Holubar M; Meng L; Alegria W; Deresinski S Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050 [TBL] [Abstract][Full Text] [Related]
8. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Yi YH; Wang JL; Yin WJ; Xu WH Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980 [No Abstract] [Full Text] [Related]
9. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718 [TBL] [Abstract][Full Text] [Related]
10. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Werth BJ; Sakoulas G; Rose WE; Pogliano J; Tewhey R; Rybak MJ Antimicrob Agents Chemother; 2013 Jan; 57(1):66-73. PubMed ID: 23070161 [TBL] [Abstract][Full Text] [Related]
11. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series. Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791 [TBL] [Abstract][Full Text] [Related]
12. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203 [TBL] [Abstract][Full Text] [Related]
13. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Rose WE; Schulz LT; Andes D; Striker R; Berti AD; Hutson PR; Shukla SK Antimicrob Agents Chemother; 2012 Oct; 56(10):5296-302. PubMed ID: 22869564 [TBL] [Abstract][Full Text] [Related]
14. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli. Morrisette T; Lagnf AM; Alosaimy S; Rybak MJ Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2199-2203. PubMed ID: 32535805 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations. Werth BJ; Barber KE; Ireland CE; Rybak MJ Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vivo efficacy of ceftaroline fosamil, vancomycin and daptomycin in a murine model of methicillin-resistant Staphylococcus aureus bacteraemia. García P; Moscoso M; Fernández MC; Fuentes-Valverde V; Pérez A; Bou G Int J Antimicrob Agents; 2023 Jul; 62(1):106836. PubMed ID: 37150362 [TBL] [Abstract][Full Text] [Related]
17. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA). Shafiq I; Bulman ZP; Spitznogle SL; Osorio JE; Reilly IS; Lesse AJ; Parameswaran GI; Mergenhagen KA; Tsuji BT Infect Dis (Lond); 2017 May; 49(5):410-416. PubMed ID: 28116950 [TBL] [Abstract][Full Text] [Related]
18. Ceftaroline as salvage therapy for complicated MRSA bacteremia: case series and analysis. Bhowmick T; Liu C; Imp B; Sharma R; Boruchoff SE Infection; 2019 Aug; 47(4):629-635. PubMed ID: 30955166 [TBL] [Abstract][Full Text] [Related]
19. Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37. Le J; Dam Q; Schweizer M; Thienphrapa W; Nizet V; Sakoulas G Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1441-7. PubMed ID: 27234592 [TBL] [Abstract][Full Text] [Related]
20. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches. Holubar M; Meng L; Deresinski S Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]